Dutch Startup HeartEye Secures €1.7 Million to Revolutionize Mobile Heart Diagnostics
Netherlands, Sunday, 24 May 2026.
HeartEye’s breakthrough lies in transforming hospital-grade 12-channel ECG testing into a wireless, user-friendly device that takes under one minute to operate. The Dutch healthtech company raised €1.675 million from ROM InWest and notable tech founders to accelerate market introduction of their patented mobile cardiac recorder, enabling early heart problem detection outside traditional hospital settings.
Healthcare Technology Innovation Transforms Cardiac Diagnostics
This funding represents a significant development in healthtech, specifically targeting mobile cardiac diagnostics technology [1]. HeartEye’s innovation addresses a critical gap in healthcare delivery by making hospital-grade cardiac monitoring accessible outside traditional medical facilities [1]. The company’s patented mobile 12-channel ECG recorder brings professional-level heart monitoring directly to patients, representing a substantial advancement in early detection of potential cardiac issues [1]. This technology aims to reduce mortality from heart conditions while simultaneously cutting healthcare costs, addressing two of the most pressing challenges in modern healthcare delivery [1].
Investment Leadership and Strategic Backing
The €1.675 million funding round was led by ROM InWest, a regional investment firm focused on supporting innovative companies in Noord-Holland [1]. The investment attracted notable participation from technology industry veterans, including Schuberg Philis co-founder Pim Berger and Mphasis co-founder Jeroen Tas [1]. Health Innovations, demonstrating confidence in HeartEye’s potential, participated as a repeat investor, marking their second investment in the company [1]. This diverse investor base combines regional development expertise with seasoned technology leadership and specialized healthcare investment experience.
Technical Innovation and Operational Efficiency
HeartEye’s fully wireless ECG recorder transforms what is currently a time-consuming and complex process requiring trained professionals into a simple, accessible procedure [1]. The device enables general practitioners, assistants, or nurses to create a 12-channel ECG in less than one minute [1]. Through the company’s digital platform, these cardiac recordings can be shared with doctors or specialists for interpretation and diagnostic support [1]. This technological advancement makes it easier to perform professional, high-quality cardiac diagnostics outside hospital settings, supporting both primary care practices and nursing homes in conducting cardiac assessments [1]. The system is designed to enable patients to eventually perform these tests independently at home [1].
Market Impact and Healthcare Efficiency Goals
The innovation addresses dual healthcare challenges by enabling earlier detection of heart problems, ensuring appropriate patients reach cardiologists promptly, while preventing unnecessary hospital referrals [1]. This approach contributes to more efficient care delivery, lower costs, and reduced workload pressure on healthcare systems [1]. The company’s strategy aligns with broader healthcare digitization trends, as recent developments show increased investment in chronic disease management and remote monitoring technologies [3]. The funding will accelerate market introduction of HeartEye’s unique ECG recorder, positioning the company to capture growing demand for accessible cardiac diagnostics [1].